Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain

被引:17
作者
Spiliotopoulos, Dimitrios [1 ]
Zhu, Jian [1 ]
Wamhoff, Eike-Christian [2 ,3 ]
Deerain, Nicholas [1 ]
Marchand, Jean-Remy [1 ]
Aretz, Jonas [2 ,3 ]
Rademacher, Christoph [2 ,3 ]
Caflisch, Amedeo [1 ]
机构
[1] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14424 Potsdam, Germany
[3] Free Univ Berlin, Dept Biol Chem & Pharm, Inst Med & Biochem, Takustr 3, D-14195 Berlin, Germany
基金
瑞士国家科学基金会;
关键词
Docking; Virtual screening; NMR spectroscopy; Epigenetics; X-ray crystallography; Bromodomain inhibitors; BINDING; INHIBITORS; LIGANDS; DOCKING; POTENT; BRD4; IDENTIFICATION; OPTIMIZATION; DESIGN;
D O I
10.1016/j.bmcl.2017.04.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Overexpression of the CREB-binding protein (CBP), a bromodomain-containing transcription coactivator involved in a variety of cellular processes, has been observed in several types of cancer with a correlation to aggressiveness. We have screened a library of nearly 1500 fragments by high-throughput docking into the CBP bromodomain followed by binding energy evaluation using a force field with electrostatic solvation. Twenty of the 39 fragments selected by virtual screening are positive in one or more ligand-observed nuclear magnetic resonance (NMR) experiments. Four crystal structures of the CBP bromodomain in complex with in silico screening hits validate the pose predicted by docking. Thus, the success ratio of the high-throughput docking procedure is 50% or 10% if one considers the validation by ligand-observed NMR spectroscopy or X-ray crystallography, respectively. Compounds 1 and 3 show favorable ligand efficiency in two different in vitro binding assays. The structure of the CBP bromodomain in the complex with the brominated pyrrole 1 suggests fragment growing by Suzuki coupling. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2472 / 2478
页数:7
相关论文
共 50 条
[21]   Discovery of Selective Ligands for Telomeric RNA G-quadruplexes (TERRA) through 19F-NMR Based Fragment Screening [J].
Garavis, Miguel ;
Lopez-Mendez, Blanca ;
Somoza, Alvaro ;
Oyarzabal, Julen ;
Dalvit, Claudio ;
Villasante, Alfredo ;
Campos-Olivas, Ramon ;
Gonzalez, Carlos .
ACS CHEMICAL BIOLOGY, 2014, 9 (07) :1559-1566
[22]   NMR-based fragment screening and lead discovery accelerated by principal component analysis [J].
Namanja, Andrew T. ;
Xu, Jia ;
Wu, Haihong ;
Sun, Qi ;
Upadhyay, Anup K. ;
Sun, Chaohong ;
Van Doren, Steven R. ;
Petros, Andrew M. .
JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (12) :675-685
[23]   Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery [J].
Li, Qingxin ;
Kang, Congbao .
MOLECULES, 2024, 29 (23)
[24]   Fragment-Based Drug Discovery for Trypanosoma brucei Glycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR Methods [J].
Ibrahim, Mohammed Auwal ;
Yamasaki, Tomoko ;
Furukawa, Koji ;
Yamasaki, Kazuhiko .
JOURNAL OF BIOCHEMISTRY, 2022, 171 (06) :619-629
[25]   A Multi-Step NMR Screen for the Identification and Evaluation of Chemical Leads for Drug Discovery [J].
Mercier, Kelly A. ;
Shortridge, Matthew D. ;
Powers, Robert .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (03) :285-295
[26]   A Benchmark Study of Protein-Fragment Complex Structure Calculations with NMR2 [J].
Torres, Felix ;
Stadler, Gabriela ;
Kwiatkowski, Witek ;
Orts, Julien .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
[27]   Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved? [J].
Mureddu, Luca G. ;
Vuister, Geerten W. .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
[28]   NMR2-Based Drug Discovery Pipeline Presented on the Oncogenic Protein KRAS [J].
Buetikofer, Matthias ;
Torres, Felix ;
Kadavath, Harindranath ;
Gaemperli, Nina ;
Saad, Marie Jose Abi ;
Zindel, Daniel ;
Coudevylle, Nicolas ;
Riek, Roland ;
Orts, Julien .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2025, 147 (16) :13200-13209
[29]   Discovery of Chemokine CXCL12 Inhibitors by Tandem Application of Virtual Screening and NMR Spectrometry [J].
Zhou, Jiao ;
Li, Wei ;
Guan, Shanyue ;
Chen, Xiaohong ;
Liu, Xiang ;
Shao, Weiyan .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (22) :5729-5737
[30]   Using NMR Spectroscopy in the Fragment-Based Drug Discovery of Small-Molecule Anticancer Targeted Therapies [J].
Diethelm-Varela, Benjamin .
CHEMMEDCHEM, 2021, 16 (05) :725-742